Back to Search Start Over

TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation

Authors :
Dreyfus, J
Galloo, X
Taramasso, M
Heitzinger, G
Benfari, G
Kresoja, K
Juarez-Casso, F
Omran, H
Bohbot, Y
Iliadis, C
Russo, G
Topilsky, Y
Weber, M
Nombela-Franco, L
Sala, A
Eixerés-Esteve, A
Iung, B
Obadia, J
Estevez Loureiro, R
Riant, E
Donal, E
Hausleiter, J
Badano, L
Le Tourneau, T
Coisne, A
Modine, T
Latib, A
Praz, F
Windecker, S
Zamorano, J
von Bardeleben, R
Tang, G
Hahn, R
Webb, J
Muraru, D
Nejjari, M
Chan, V
De Bonis, M
Carnero-Alcazar, M
Nickenig, G
Pfister, R
Tribouilloy, C
Rudolph, V
Crestanello, J
Lurz, P
Bartko, P
Maisano, F
Bax, J
Enriquez-Sarano, M
Messika-Zeitoun, D
Dreyfus, Julien
Galloo, Xavier
Taramasso, Maurizio
Heitzinger, Gregor
Benfari, Giovanni
Kresoja, Karl-Patrick
Juarez-Casso, Fernando
Omran, Hazem
Bohbot, Yohann
Iliadis, Christos
Russo, Giulio
Topilsky, Yan
Weber, Marcel
Nombela-Franco, Luis
Sala, Alessandra
Eixerés-Esteve, Andrea
Iung, Bernard
Obadia, Jean-François
Estevez Loureiro, Rodrigo
Riant, Elisabeth
Donal, Erwan
Hausleiter, Jörg
Badano, Luigi
Le Tourneau, Thierry
Coisne, Augustin
Modine, Thomas
Latib, Azeem
Praz, Fabien
Windecker, Stephan
Zamorano, Jose Luis
von Bardeleben, Ralph Stephan
Tang, Gilbert H L
Hahn, Rebecca
Webb, John
Muraru, Denisa
Nejjari, Mohammed
Chan, Vincent
De Bonis, Michele
Carnero-Alcazar, Manuel
Nickenig, Georg
Pfister, Roman
Tribouilloy, Christophe
Rudolph, Volker
Crestanello, Juan
Lurz, Philipp
Bartko, Philipp
Maisano, Francesco
Bax, Jeroen
Enriquez-Sarano, Maurice
Messika-Zeitoun, David
Dreyfus, J
Galloo, X
Taramasso, M
Heitzinger, G
Benfari, G
Kresoja, K
Juarez-Casso, F
Omran, H
Bohbot, Y
Iliadis, C
Russo, G
Topilsky, Y
Weber, M
Nombela-Franco, L
Sala, A
Eixerés-Esteve, A
Iung, B
Obadia, J
Estevez Loureiro, R
Riant, E
Donal, E
Hausleiter, J
Badano, L
Le Tourneau, T
Coisne, A
Modine, T
Latib, A
Praz, F
Windecker, S
Zamorano, J
von Bardeleben, R
Tang, G
Hahn, R
Webb, J
Muraru, D
Nejjari, M
Chan, V
De Bonis, M
Carnero-Alcazar, M
Nickenig, G
Pfister, R
Tribouilloy, C
Rudolph, V
Crestanello, J
Lurz, P
Bartko, P
Maisano, F
Bax, J
Enriquez-Sarano, M
Messika-Zeitoun, D
Dreyfus, Julien
Galloo, Xavier
Taramasso, Maurizio
Heitzinger, Gregor
Benfari, Giovanni
Kresoja, Karl-Patrick
Juarez-Casso, Fernando
Omran, Hazem
Bohbot, Yohann
Iliadis, Christos
Russo, Giulio
Topilsky, Yan
Weber, Marcel
Nombela-Franco, Luis
Sala, Alessandra
Eixerés-Esteve, Andrea
Iung, Bernard
Obadia, Jean-François
Estevez Loureiro, Rodrigo
Riant, Elisabeth
Donal, Erwan
Hausleiter, Jörg
Badano, Luigi
Le Tourneau, Thierry
Coisne, Augustin
Modine, Thomas
Latib, Azeem
Praz, Fabien
Windecker, Stephan
Zamorano, Jose Luis
von Bardeleben, Ralph Stephan
Tang, Gilbert H L
Hahn, Rebecca
Webb, John
Muraru, Denisa
Nejjari, Mohammed
Chan, Vincent
De Bonis, Michele
Carnero-Alcazar, Manuel
Nickenig, Georg
Pfister, Roman
Tribouilloy, Christophe
Rudolph, Volker
Crestanello, Juan
Lurz, Philipp
Bartko, Philipp
Maisano, Francesco
Bax, Jeroen
Enriquez-Sarano, Maurice
Messika-Zeitoun, David
Publication Year :
2024

Abstract

BACKGROUND AND AIMS: Benefit of tricuspid regurgitation (TR) correction and timing of intervention are unclear. This study aimed to compare survival rates after surgical or transcatheter intervention to conservative management according to a TR clinical stage as assessed using the TRI-SCORE. METHODS: A total of 2,413 patients with severe isolated functional TR were enrolled in TRIGISTRY (1217 conservatively managed, 551 isolated tricuspid valve surgery, and 645 transcatheter valve repair). The primary endpoint was survival at 2 years. RESULTS: The TRI-SCORE was low (≤3) in 32%, intermediate (4-5) in 33%, and high (≥6) in 35%. A successful correction was achieved in 97% and 65% of patients in the surgical and transcatheter groups, respectively. Survival rates decreased with the TRI-SCORE in the three treatment groups (all P < .0001). In the low TRI-SCORE category, survival rates were higher in the surgical and transcatheter groups than in the conservative management group (93%, 87%, and 79%, respectively, P = .0002). In the intermediate category, no significant difference between groups was observed overall (80%, 71%, and 71%, respectively, P = .13) but benefit of the intervention became significant when the analysis was restricted to patients with successful correction (80%, 81%, and 71%, respectively, P = .009). In the high TRI-SCORE category, survival was not different to conservative management in the surgical and successful repair group (61% and 68% vs 58%, P = .26 and P = .18 respectively). CONCLUSIONS: Survival progressively decreased with the TRI-SCORE irrespective of treatment modality. Compared to conservative management, an early and successful surgical or transcatheter intervention improved 2-year survival in patients at low and, to a lower extent, intermediate TRI-SCORE, while no benefit was observed in the high TRI-SCORE category.

Details

Database :
OAIster
Notes :
STAMPA, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1415733592
Document Type :
Electronic Resource